Sci-Tech

Excitement builds for long-acting TB treatments, but research still at early stage

By Catherine Tomlinson

South Africa

Competition law has again worked to fight a bad drug patent, but we need other solutions

By Fatima Hassan and Leena Menghaney for Spotlight

Sci-Tech

Faster tests, shorter treatments — how new tech could help slow down drug-resistant TB

By Zano Kunene

South Africa

More bullying? J&J will be investigated for high TB drug prices and abuse of patent laws

By Mia Malan for the Bhekisisa Centre for Health Journalism

South Africa

#SliceOfLife – how I beat a rare form of TB, but lost my hearing

By Nicole Ludolph

South Africa

Is the future of South Africa’s TB plans locked up in the mysterious minds of teens?

By Joan van Dyk for the Bhekisisa Centre for Health Journalism

South Africa

Shorter, simpler drug-resistant TB treatment expected in SA later in 2022

By Catherine Tomlinson

South Africa

Minimising nasty side effects: Important TB drug is effective at lower dose, study finds

By Tiyese Jeranji and Marcus Low for Spotlight

South Africa

Survivors and activists demand increased action against TB

By Amy Green for Health-e news

South Africa

Drug-resistant TB breakthrough as new drug approved for use in United States after SA trials

By Spotlight

South Africa

TB patients still shunned by families

By Amy Green for Health-e news

South Africa

‘You can’t fight TB if you don’t show up’

By Amy Green for Health-e news